Ionis Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Ionis Pharmaceuticals has a total shareholder equity of $386.7M and total debt of $1.8B, which brings its debt-to-equity ratio to 462.5%. Its total assets and total liabilities are $3.0B and $2.6B respectively.
Key information
462.5%
Debt to equity ratio
US$1.79b
Debt
Interest coverage ratio | n/a |
Cash | US$2.34b |
Equity | US$386.69m |
Total liabilities | US$2.60b |
Total assets | US$2.99b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0JDI's short term assets ($2.6B) exceed its short term liabilities ($448.1M).
Long Term Liabilities: 0JDI's short term assets ($2.6B) exceed its long term liabilities ($2.2B).
Debt to Equity History and Analysis
Debt Level: 0JDI has more cash than its total debt.
Reducing Debt: 0JDI's debt to equity ratio has increased from 54% to 462.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0JDI has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0JDI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.